This comprehensive practice parameter for allergic rhinitis (AR) and nonallergic rhinitis
(NAR) provides updated guidance on diagnosis, assessment, selection of monotherapy and …

An adverse drug reaction (ADR) is defined as a response to a medicinal product which is
noxious and unintended. ADRs are an important cause of morbidity and mortality and …

Objective To review, critically analyze and synthesize knowledge from the international
literature regarding the association between allergic rhinitis (AR) and sleep disorders, the …

Background: The United States Food and Drug Administration issued a black box warning
on the mental health adverse effects of montelukast in 2020. Age-related effects on the risk …

Se define como reacción adversa a medicamentos (RAM) cualquier respuesta nociva y no
intencionada a un medicamento. Las RAM constituyen una importante causa de …

Aims Montelukast (MTK) is an antagonist of the cysteinyl leukotrienes receptor 1 widely used
to manage asthma symptoms among adults and children. However, it has been associated …

Montelukast, a selective leukotriene receptor antagonist, is recommended in guidelines for
the treatment of asthma in both children and adults. However, its effectiveness is debated …

Objective To systematically review the literature on anti-inflammatory medications for
treating pediatric obstructive sleep apnea and perform meta-analysis of the available data …

Objective To examine the association between montelukast prescription and
neuropsychiatric events in children with asthma. Study design A matched, nested case …

Although the problem of adenoid hypertrophy (AH) has been diagnosed and treated by
doctors and scientists from around the world for the last 150 years, there is still no …